Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...

Dividend safety or growth? It’s a common question that many investors on Wall Street grapple with as they seek to balance ...

This was the stock's second consecutive day of gains.

On Monday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $21.44 which represents a slight increase of $0.66 or 3.18% from the prior close of $20.78. The stock opened at $ and touched ...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Check the time stamp on this data. Updated AI-Generated Signals for Kenvue Inc. (KVUE) available here: KVUE. Type a few symbols and Take a Trial. The signals for these will appear immediately on your ...

Dakota Wealth Management raised its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 25.6% during the 4th quarter, ...

Penelope Giraud will be taking over the role and leading the strategic direction of the Neutrogena, Aveeno and Dr. Ci Labo ...

Kenvue isn't growing as quickly as Eli Lilly or Zoetis, but it offers investors a strong starting point for dividend income.

Kenvue Inc. closed 13.37% below its 52-week high of $24.46, which the company achieved on November 26th.

L’Oréal veteran Penelope Giraud will lead the direction of the company’s beauty brands Neutrogena, Aveeno and Dr. Ci Labo in ...